Catalyst Biosciences Stock Analysis
Technical stock analysis for Fri 16'th Nov 2018
| Shorts | n/a |
| Cash | n/a |
| Loans | n/a |
| Beta | 1.97 |
| ROA | -29.76 |
Catalyst Biosciences gained 1.86% in the last trading day, rising from $10.76 to $10.96 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a 1.01% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 174 576 more shares were traded than the day before. In total, 262 352 shares bought and sold for approximately $2.88 million.
Trend
Catalyst Biosciences lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $11.25 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -3.02% during the next 3 months and, with 90% probability hold a price between $8.52 and $10.91 at the end of this period.
Signals
Only positive signals in the chart today. Catalyst Biosciences holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $10.65 and $10.14. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday November 14, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 68 and the stock is currently not being overbought or oversold
Support & Resistance
Catalyst Biosciences finds support from accumulated volume at $10.85.
Risk
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.84 between high and low, or 8.13%. For the last week, the stock has had a daily average volatility of 7.13%.
Our recommended stoploss: $10.45 (-4.66%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)
Overall risk:
Very Low Low Medium High Very High
Evaluation
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.
| CBIO $10.96 $0.20(1.86%) |
|
CBIO is up $0.20 today, but where's it headed in 2019? |
| Zacks Investment Research is releasing its prediction for CBIO based on the 1-3 month system that more than doubles the S&P 500. Click here – the CBIO analysis is free » |
Last donation
Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features
Proudly made at
in partnership with
